Genprex, Inc. (GNPX): Price and Financial Metrics

Genprex, Inc. (GNPX): $0.47

0.00 (-1.01%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add GNPX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#182 of 337

in industry

GNPX Price/Volume Stats

Current price $0.47 52-week high $5.41
Prev. close $0.48 52-week low $0.28
Day low $0.41 Volume 16,734,559
Day high $0.55 Avg. volume 898,648
50-day MA $0.80 Dividend yield N/A
200-day MA $1.35 Market Cap 4.01M

GNPX Stock Price Chart Interactive Chart >


Genprex, Inc. (GNPX) Company Bio


Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.


GNPX Latest News Stream


Event/Time News Detail
Loading, please wait...

GNPX Latest Social Stream


Loading social stream, please wait...

View Full GNPX Social Stream

GNPX Price Returns

1-mo -36.31%
3-mo -70.63%
6-mo -27.47%
1-year -89.89%
3-year -99.47%
5-year -99.73%
YTD -44.81%
2024 -90.74%
2023 -84.14%
2022 10.69%
2021 -68.43%
2020 1,196.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!